Ritlecitinib is a pyrrolopyrimidine compound that functions as a dual inhibitor of Janus kinase 3 and the TEC family of tyrosine kinases. It is an anti-inflammatory and immunosuppressive agent, used primarily for research and pharmaceutical manufacturing as an active pharmaceutical ingredient.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1792180-81-4
Ritlecitinib tosylate
active pharmaceutical ingredient
Daridorexant hydrochloride
active pharmaceutical ingredient
Magnesium lactate dihydrate
magnesium supplement active ingredient
Bortezomib
active pharmaceutical ingredient
Caspofungin acetate
active pharmaceutical ingredient
N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
n.a
Tofacitinib
active pharmaceutical ingredient
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
active pharmaceutical ingredient
1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
CBRJPFGIXUFMTM-WDEREUQCSA-N
C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3